A. Hamano

A novel monoclonal antibody to fibrin monomer and soluble fibrin for the detection of soluble fibrin in plasma.

Y. Sakata, M. Umeda, Y. Takeda, 2002, Clinica chimica acta; international journal of clinical chemistry.

Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of gammaAla327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism.

Y. Kashiwakura, A. Ishiwata, S. Madoiwa, 2004, Blood.

Thrombophilic dysfibrinogen Tokyo V with the amino acid substitution of (cid:1) Ala327Thr: formation of fragile but fibrinolysis-resistant fibrin clots and its relevance to arterial thromboembolism

Y. Kashiwakura, A. Ishiwata, S. Madoiwa, 2004 .

Detection of soluble HFE associated with soluble transferrin receptor in human serum.

Kazuya Sato, K. Ohnishi, Y. Kohgo, 2011, International journal of molecular medicine.

Imaging of thrombosis and microcirculation in mouse lungs of initial melanoma metastasis with in vivo cryotechnique.

I. Saiki, T. Jin, Y. Saitoh, 2014, Microvascular research.

Latex immunoturbidimetric assay for soluble fibrin complex.

J. Mimuro, Y. Sakata, M. Umeda, 2005, Clinical chemistry.

Hypofibrinogenemia caused by a nonsense mutation in the fibrinogen Bβ chain gene

J. Mimuro, Y. Sakata, M. Matsuda, 2003, Journal of thrombosis and haemostasis : JTH.

Impact of acute cellular rejection on coagulation and fibrinolysis biomarkers within the immediate post‐operative period in pediatric liver transplantation

T. Ohmori, Y. Kashiwakura, S. Madoiwa, 2010, Pediatric transplantation.